Search results for: 'ride rare'

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

27 Dec 2024  |  Global  |  Market Research

Ride-hailing Advertising Market, North America, 2024 to 2045

Ride-hailing Advertising is Experiencing Transformational Growth due to the Use of AI and Advanced Display Technology

Infographics

×

This Frost & Sullivan report examines the ride-hailing advertising industry in North America, focusing on both in-app and on-car advertising. It explores how advertising has become a significant revenue stream for ride-hailing companies, analyzing current and future trends. The ride-hailing industry has evolved its business model over the years, de...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

09 Nov 2022  |  Global  |  Technology Research

Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

Infographics

×

Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...

The Mobility Technology Opportunity Engine (TOE) provides profiles of innovations related to Ride-hailing Services with Autonomous Vehicle, Eco-friendly Transportation through Advanced Electric Carsharing, Customized Shared Transportation Services, Urban Traffic Management, Automotive Power Inductors and Proton Exchange Membrane (PEM) Modules.The p...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advancements in nanotechnology for various enhanced industrial applications. The featured innovations include Photocatalytic Conversion of Methane to Clean Hydrogen and Carbon Nanotubes, Stable Carbon Nanotube Dispersions for Enhanced Battery Performance, Adv...

Demand for electric motors (e-motor) has skyrocketed in recent years, driven by the growing shift toward electric vehicles (EVs), stricter carbon emission regulations, government incentives, and advancements in battery technology. Currently, interior permanent magnet synchronous motors (IPMSM) dominate most of the EV traction motor market, thanks t...